HC Wainwright & Co. analyst Raghuram Selvaraju maintains Taro Pharmaceutical Indus (NYSE:TARO) with a Buy and lowers the price target from $54 to $35.
What’s Going On With Tivic Health Systems (TIVC) Stock Today?
Tivic Health Systems, Inc. (NASDAQ: TIVC) shares are rocketing higher Tuesday. The stock remains down more than 30% over the last 30 days.